Exploring options for improving healthcare

American Heart Journal

Volumn 147, Issue 1, 2004, Pages 23-30

  Wang, Stanley S ^a,b   Mendelson, Daniel N ^b   Schulman, Kevin A ^a   Mark, Daniel B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Health Strategies Consultancy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CONFERENCE PAPER; FOOD AND DRUG ADMINISTRATION; HEALTH CARE; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; MEDICAID; MEDICARE; PRIORITY JOURNAL;

EID: 0348047557     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2003.09.006     Document Type: Conference Paper

References (34)

1. Department of Health and Human Services, ASPE Regulatory Reform Initiative. Available at: www.regreform.hhs.gov/. Accessed March 17, 2003.
2. The Henry J. Kaiser Family Foundation, Daily Health Policy Report, Jan. 2, 2002. Available at: www.kaisernetwork.org/daily_reports/ rep_index.cfm?hint= 3&DR_ID=8743. Accessed March 17, 2003.
3. HR 810, §502 (108th Congress, 2003).
4. FDA. Protecting consumers, promoting public health. Available at: www.fda.gov/oc/opacom/fda101/sld003.html. Accessed March 18, 2003.
5. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ 2003;22: 325-30.
6. FDA. FDA and the drug development process: how the agency ensures that drugs are safe and effective. FS02-1, February, 2002. Available at: www.fda.gov/opacom/factsheets/justthefacts/17drg-dev.html. Accessed March 18, 2003.
7. GAO. Medicare: technology assessment and coverage decisions. GAO/HEHS-94-195FS (Oct. 11, 1999).
8. Medical Technology Leadership Forum. Medicare coverage policy: the balance between local and national decision making, June 28, 2002. [citing HHS Report to Congress on National Coverage Determinations, June 2002; www.cms.hhs.gov/coverage/8a.aspp]. Available at: www.mtlf.org/publications/ MedicareCoverage Paper1-03.pdf. Accessed April 8, 2003.
9. 21 CFR §§312 et seq. (2003); 21 CFR §§360 et seq. (2003).
10. 42 USC §1395y(a) (2002).
11. FDA. The FDA modernization act of 1997. BG97-13, Nov. 21, 1997. Available at: www.fda.gov/opacom/backgrounders/modact.html. Accessed March 18, 2003.
12. FDA. Milestones in U.S. food and drug law history. BG99-4, May 3, 1999. Available at: www.fda.gov/opacom/backgrounders/ miles.html. Accessed March 18, 2003).
13. 21 CFR §§312.20-312.23 (2003).
14. 21 CFR §314.50 (2003).
15. FDA. The FDA's drug review process: ensuring drugs are safe and effective. 02-3242, Sept. 2002. Available at: www.fda.gov/fdac/ features/2002/402_drug.html. Accessed March 18, 2003.
16. 21 USC §360c (2002).
17. 21 CFR Subchapter H (2003).
18. 21 CFR Part 807 (2003).
19. 21 CFR Part 814 (2003).
20. Pub. L. 89-97.
21. HHS. The new Centers for Medicare & Medicaid Services (CMS). Available at: www.hhs.gov/news/press/2001pres/ 20010614a.html. Accessed March 12, 2003.
22. 42 USC §1395y(a) (2002).
23. Medical Technology Leadership Forum. Medicare coverage policy: the balance between local and national decision-making, June 28, 2002 [citing Foote SB. Why Medicare cannot promulgate a national coverage rule: a case of regula mortis. J Health Politics Policy Law, Oct. 2002]. Available at: www.mtlf.org/publications/ MedicareCoveragePaper1-03.pdf. Accessed March 19, 2003.
24. Notice of Intent to Publish a Proposed Rule, 65 Fed. Reg. 31124 (May 16, 2000).
25. FDA, CMS reviewers appraise cost effectiveness; ICD decision scrutinized. The Gray Sheet: Medical Devices, Diagnostics & Instrumentation 2003;29:18.
26. Reiss JB. Commentary on payment and reimbursement issues affecting the marketing of drugs, medical devices, and biologics, with emphasis on the Anti-Kickback Statute and Stark II. Food Drug Law J 1997;52:99-108.
27. General Notice, 64 Fed. Reg. 22619, 22621 (Apr. 27, 1999).
28. CMS Ruling No. 02-1, Oct. 1, 2002.
29. General Notice, 64 Fed. Reg. 22619 (Apr. 27, 1999).
30. Proposed Rule, 67 Fed. Reg. 54533 (Aug. 22, 2002).
31. CMS MCAC Meeting, Feb. 12, 2003 [transcript]. Available at: www.cms.hhs.gov/mcac/id39-5.pdf. Accessed April 8, 2003.
32. NICE. General information about technology appraisals. Available at: www.nice.org.uk/cat.asp?c=57705. Accessed March 20, 2003.
33. Final Rule 67. Fed. Reg. 49981, 50003 (Aug. 1, 2002).
34. FDA. FDA news: FDA approves drug-eluting stent for clogged heart arteries P03-31. Available at: www.fda.gov/bbs/topics/ NEWS/2003/NEW00896.html. Accessed April 30, 2003.